BioRelix's Series A Round

BioRelix raised a round of funding on May 16, 2007.

BioRelix is discovering and developing new treatments for infectious diseases that target RiboSwitches, a class of RNA drug targets found in pathogenic bacteria and fungi. Riboswitches are short stret…

Articles about BioRelix's Series A Round: